Physician profile
Keith Micetich
NPI 1427026137
$792.65
in general payments reported to CMS, 2019-2025
17 companies · $30.10 in 2025
The $30.10 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $12.93 · 2021: $120 · 2022: $286 · 2023: $146 · 2024: $28.33 · 2025: $30.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $204.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $271.41 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $56.67 | 2021-2023 | |
| Amgen INC. | $53.45 | 2019-2022 | |
| Pfizer INC. | $50.98 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.99 | 2023 | |
| Merck Sharp & Dohme LLC | $41.93 | 2019-2022 | |
| Coopersurgical, INC. | $39.01 | 2023 | Fisherbrand Disposable Liquid Infant Heel Warmer |
| Daiichi Sankyo INC. | $34.25 | 2021-2023 | Injectafer |
| Hologic Sales and Service, LLC | $30.10 | 2025 | Aptima |
| Novo Nordisk INC | $28.33 | 2024 | Wegovy |
| Kowa Pharmaceuticals America, INC. | $28.07 | 2022 | |
| Glaxosmithkline, LLC. | $24.88 | 2022 | |
| Organon LLC | $22.31 | 2022 | |
| Ethicon US, LLC | $20.30 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.10 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $14.94 | 2021 | |
| Allergan, INC. | $12.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Micetich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.